Antithrombin III Concentrate After Liver Transplantation

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study was designed to demonstrate more effective administration method of AT-III in immediate post-liver transplantation period.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Antithrombin III; Antithrombins

Criteria

Inclusion Criteria:

• Scheduled operation

• Living donor liver transplantation

• Adult patients (>=18 years old)

Exclusion Criteria:

• Patients under 18 years old

• Emergency operation

• Deceased donor liver transplantation